Tomáš Hofman 🍅 (@capslocked_me) 's Twitter Profile
Tomáš Hofman 🍅

@capslocked_me

🇨🇿 YOUNG IMMUNOLOGIST TRYING TO FIND SOMETHING COOL THAT COULD BEAT CANCER 🇩🇪

ID: 1239122596102365189

calendar_today15-03-2020 09:34:56

78 Tweet

57 Takipçi

209 Takip Edilen

Tomáš Hofman 🍅 (@capslocked_me) 's Twitter Profile Photo

MY PHD JOURNEY IS OVER. IT WAS LOONG, HARD AND MENTALLY DEMANDING. UPS AND DOWNS AND DOWNS AND DOWNS. STARTED AS NEWBIES, GROWN INTO FULL INDEPENDENCY. #PhD WHAT A RIDE WE HAD Irene Garcés Lázaro

MY PHD JOURNEY IS OVER.
IT WAS LOONG, HARD AND MENTALLY DEMANDING. UPS AND DOWNS AND DOWNS AND DOWNS. STARTED AS NEWBIES, GROWN INTO FULL INDEPENDENCY. #PhD

WHAT A RIDE WE HAD <a href="/IreneGalaz_/">Irene Garcés Lázaro</a>
Tomáš Hofman 🍅 (@capslocked_me) 's Twitter Profile Photo

WOULD I DO IT AGAIN? YES, IF I HAVE THE SAME PEOPLE I DID MY PHD WITH. DESPITE ALL THE NEGATIVE ASPECTS OF PHD, I DID HAVE A GREAT TIME THANKS TO THEM. SUPPORTING EACH OTHER IN LONG EXPERIMENTS, STAYING LATE, PIZZA, BEER, GAMES IN OUR OFFICE, PUBS AND JUST FUN. I MISS THAT.

WOULD I DO IT AGAIN? 
YES, IF I HAVE THE SAME PEOPLE  I DID MY PHD WITH. DESPITE ALL THE NEGATIVE ASPECTS OF PHD, I DID HAVE A GREAT TIME THANKS TO THEM. SUPPORTING EACH OTHER IN LONG EXPERIMENTS, STAYING LATE,  PIZZA, BEER, GAMES IN OUR OFFICE, PUBS AND JUST FUN.

I MISS THAT.
Tomáš Hofman 🍅 (@capslocked_me) 's Twitter Profile Photo

MY BABY IS OUT! ♥️ CHECK IT OUT AND LET ME KNOW WHAT YOU THINK! #JITC #NK #immunotherapy #NKCells #Cancer Cerwenka Lab doi.org/10.1136/jitc-2…

Waggoner Lab (@labwaggoner) 's Twitter Profile Photo

NK cell IFNγ induces resistance of tumors to NK cells by upregulating classical & non-classical MHC-I, where therapeutic combination of monalizumab/lirilumab/DX9 may fully restore the antitumor response across NK cell subsets Tomáš Hofman 🍅 Cerwenka Lab jitc.bmj.com/content/12/7/e…

NK cell IFNγ induces resistance of tumors to NK cells by upregulating classical &amp; non-classical MHC-I, where therapeutic combination of monalizumab/lirilumab/DX9 may fully restore the antitumor response across NK cell subsets <a href="/capslocked_me/">Tomáš Hofman 🍅</a> <a href="/CerwenkaLab/">Cerwenka Lab</a> 
jitc.bmj.com/content/12/7/e…